This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Flatiron Health, Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Edward Liu
Introduction
Edward Liu is a notable inventor based in Brooklyn, NY, who has made significant contributions to the field of healthcare technology. He holds a total of 3 patents that focus on improving clinical trial processes through advanced systems and methods. His work is instrumental in enhancing patient matching for clinical trials, ultimately aiming to improve patient outcomes.
Latest Patents
One of Edward Liu's latest patents is a "Clinical trial matching system using inferred biomarker status." This innovative model-assisted system is designed to identify a group of patients for a cohort using a generalized biomarker model. The system includes a processor programmed to provide a first biomarker associated with a cohort and to receive outputs indicating individuals' likelihoods of having certain attributes. This technology aims to streamline the process of patient selection for clinical trials based on biomarker data.
Another significant patent is for "Systems and methods for determining a genomic testing status." This computer-implemented system identifies patients for trials based on genomic testing criteria. It utilizes machine learning to analyze unstructured information from patient records, determining the likelihood of genomic testing occurrence. The system then assesses whether the genomic testing status meets the trial's criteria, facilitating the inclusion of eligible patients in clinical studies.
Career Highlights
Edward Liu is currently employed at Flatiron Health, Inc., a company dedicated to improving cancer care through data and technology. His role involves leveraging his expertise in biomarker models and genomic testing to enhance clinical trial methodologies. His contributions are vital in advancing the integration of technology in healthcare.
Collaborations
Edward collaborates with talented professionals in his field, including Lauren Sutton and Alexander Padmos. These partnerships foster innovation and drive the development of cutting-edge solutions in clinical trial processes.
Conclusion
Edward Liu's work exemplifies the intersection of technology and healthcare, showcasing how innovative systems can transform clinical trial methodologies. His patents reflect a commitment to improving patient outcomes through advanced data-driven approaches.